Yanbin Sun
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Circular RNAs in diseases 3
-
- Lung Cancer Treatments and Mutations 4
- Medical Imaging and Pathology Studies 3
- Co-authors
- Shun Xu (6 shared papers)Shun Xu (3 shared papers)Qiming Shen (2 shared papers)Zhaohua Miao (3 shared papers)Zhengbao Zha (3 shared papers)Xianwen Wang (2 shared papers)Xiaoxi Fan (2 shared papers)Fei Gong (1 shared paper)
- Journals
- OncoTargets and Therapy (2 papers)BioMed Research International (2 papers)Acta Pharmaceutica Sinica B (1 paper)Lung (1 paper)Biological Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesVietnam
In The Last Decade
Yanbin Sun
39 papers receiving 635 citations
Peers
Comparison fields: 5 of 92
- Cancer Research 198
- Biomaterials 69
- Molecular Biology 284
- Biomedical Engineering 165
- Metals and Alloys 8
Countries citing papers authored by Yanbin Sun
This map shows the geographic impact of Yanbin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanbin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanbin Sun more than expected).
Fields of papers citing papers by Yanbin Sun
This network shows the impact of papers produced by Yanbin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanbin Sun. The network helps show where Yanbin Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanbin Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 124 | |
| 2 | 2017 | 91 | |
| 3 | 2019 | 56 | |
| 4 | 2014 | 48 | |
| 5 | 2018 | 25 | |
| 6 | 2013 | 24 | |
| 7 | 2020 | 23 | |
| 8 | 2013 | 21 | |
| 9 | 2018 | 18 | |
| 10 | 2014 | 18 | |
| 11 | 2015 | 17 | |
| 12 | 2022 | 17 | |
| 13 | 2024 | 16 | |
| 14 | 2022 | 14 | |
| 15 | 2018 | 10 | |
| 16 | 2020 | 10 | |
| 17 | 2025 | 10 | |
| 18 | 2020 | 10 | |
| 19 | 2020 | 10 | |
| 20 | 2018 | 10 |
About Yanbin Sun
Yanbin Sun is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Biomedical Engineering, Oncology and Materials Chemistry, having authored 40 papers that have together received 640 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (6 papers), Cancer-related molecular mechanisms research (4 papers), Lung Cancer Treatments and Mutations (4 papers), Medical Imaging and Pathology Studies (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Circular RNAs in diseases (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Cancer Research (198 citations), Biomaterials (69 citations), Molecular Biology (284 citations), Biomedical Engineering (165 citations) and Metals and Alloys (8 citations). Yanbin Sun has collaborated with scholars based in China, United States and Vietnam. Frequent co-authors include Shun Xu, Shun Xu, Qiming Shen, Zhaohua Miao, Zhengbao Zha, Xianwen Wang, Xiaoxi Fan, Fei Gong, Liang Cheng and Qianqian Shi. Their work appears in journals such as OncoTargets and Therapy, BioMed Research International, Acta Pharmaceutica Sinica B, Lung and Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.